SCHEMBL22084257

SCHEMBL22084257

CC(C)c1cc(C(F)F)nc2c(F)cccc12

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.38
▸ ADORA2A P29274 6/20 0.37
▸ TRPV4 Q9HBA0 1/20 0.34
▸ HTR1B P28222 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ GPR65 Q8IYL9 1/20 0.34
▸ ADORA1 P30542 3/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ GRM2 Q14416 1/20 0.33
▸ CYP2D6 P10635 1/20 0.32
▸ AURKA O14965 1/20 0.32
▸ PARP1 P09874 2/20 0.31
▸ TNKS O95271 1/20 0.31
▸ TNKS2 Q9H2K2 1/20 0.31
▸ RPS6KA3 P51812 1/20 0.31
▸ KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19148561 0.89 ADORA2A (0.39) LMNAADORA2AADORA1TDP1L3MBTL1
SCHEMBL20277896 0.81 LMNA (0.43) LMNAADORA2ATRPV4ADORA1TDP1
SCHEMBL22041584 0.78 ADORA2A (0.41) ADORA2AADORA1L3MBTL1GRM2CYP2D6
SCHEMBL29659722 0.78 ADORA2A (0.41) ADORA2AADORA1L3MBTL1GRM2CYP2D6
SCHEMBL13409387 0.75 LMNA (0.35) LMNAADORA2AHTR2BADORA1CYP2D6
SCHEMBL19150087 0.71 KDM4E (0.43) LMNAPARP1TNKSTNKS2
SCHEMBL21173367 0.70 PARP1 (0.41) LMNAADORA2AADORA1L3MBTL1AURKA
SCHEMBL19149180 0.70 EPRS1 (0.36) LMNATDP1L3MBTL1
SCHEMBL19148554 0.69 KCNH2 (0.42) LMNAADORA2AHTR2BADORA1GRM2
SCHEMBL29659679 0.68 ADORA2A (0.35) ADORA2AADORA1TDP1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020113554-A1 QUINOLINE DERIVATIVE AND PREPARATION METHOD AND APPLICATION THEREOF 东莞市东阳光农药研发有限公司 2020-06-11 — — WO disclosed
Send feedback